论文部分内容阅读
目的分析奥美拉唑联合血凝酶在治疗消化性溃疡合并出血患者中的临床效果,总结医学经验,从而为临床提供借鉴用意义。方法本次研究病例我们选择的是2013年4月-2014年9月这段时期内确诊收治的消化性溃疡合并出血患者,共70例。按照患者入院顺序进行编号、抽取,奇数为对照组,偶数为实验组,各为35例。对照组给予奥美拉唑治疗,实验组则加入血凝酶治疗。然后收集所有患者的临床资料,对其结果进行回顾性分析。结果一段时间的治疗发现,实验组治疗有效率为94.3%(33/35),对照组治疗有效率为82.9%(29/35),实验组的数值明显高于对照组,组间的差异具有统计学意义(P<0.05)。结论奥美拉唑联合血凝酶可以有效治疗消化性溃疡合并出血,具有一定的科学性和安全性,建议推广。
Objective To analyze the clinical effects of omeprazole combined with hemagglutinin in the treatment of patients with peptic ulcer bleeding and summarize the medical experience so as to provide reference for clinical use. Methods We selected 70 cases of patients with peptic ulcer complicated with bleeding diagnosed during the period from April 2013 to September 2014 in this study. In accordance with the order of patients admitted to hospital number, extraction, odd number for the control group, even for the experimental group, each 35 cases. The control group was treated with omeprazole, while the experimental group was treated with hemagglutinin. All patients were then collected for clinical data and their results were retrospectively analyzed. Results After a period of treatment, the effective rate was 94.3% (33/35) in the experimental group and 82.9% (29/35) in the control group. The difference between the experimental group and the control group was statistically significant Statistical significance (P <0.05). Conclusion omeprazole combined with hemagglutinin can effectively treat peptic ulcer bleeding, with a certain degree of scientific and safety, it is recommended to promote.